DM is associated with several autoantibodies, such as antinuclear matrix protein 2 (NXP-2), antitranscriptional intermediary factor 1, and antimelanoma differentiation-associated protein 5; cutaneous manifestations vary depending upon the associated autoantibodies.1 Here, MORC3 is linked to dermatomyositis.